Celldex Therapeutics Inc (CLDX)
Operating Income Growth
-38.81%
TTM · Period ending:
CLDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-38.81%period ending
Latest reported-38.81%period ending
CLDX TTM Operating Income YoY % (25.00% → -38.81%)
Year-over-year change
High-resolution chart · PNG
CLDX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -34.8771% | |
| -24.1139% | |
| -26.0372% | |
| -51.1937% | |
| -47.8873% | |
| -46.3768% | |
| -30.5556% | |
| -2.5974% | |
| 18.3908% | |
| 22.4719% | |
| 36.8421% | |
| 34.7458% | |
| 29.2683% | |
| 33.0827% | |
| 0.8696% | |
| 0% | |
| -14.9533% | |
| -34.3434% | |
| -16.1616% | |
| -24.2105% | |
| -10.3093% | |
| 0% | |
| -8.7912% | |
| -7.9545% | |
| -22.7848% | |
| -47.7612% | |
| -33.8235% | |
| -41.0714% | |
| -6.3492% | |
| -4.6154% | |
| 8.1967% | |
| -26% | |
| -44.4444% | |
| -90.3226% | |
| -165.2174% | |
| -554.5455% | |
| -202.2727% | |
| -10.7143% | |
| -228.5714% | |
| 191.6667% | |
| 375% | |
| -833.3333% | |
| 0% | |
| 14.2857% | |
| 23.8095% | |
| -400% | |
| -16.6667% | |
| -16.6667% | |
| -5% | |
| 125% | |
| 45.4545% | |
| 25% |